CDH11 and prostate cancer: Cadherin-11 promotes bone metastasis in a mouse model and its expression increases as the tumour progresses from primary prostate cancer to metastatic disease in lymph nodes and especially in bone (Gravdal et al, 2007; Chu et al, 2008).